Shortage pharmaceutical of items; including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and other relevant pharmaceuticals…
Ended Awarded Last action
- Contract number
- HT001417F0150
- Awardee
-
TDS Med, Inc. UEI L8RFE2B8JCK4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $300,000
Award facts
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6605 Navigational Instruments
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $300,000 |
About this award
This federal contract award to TDS Med, Inc., a self-certified small disadvantaged business, was issued by the Defense Health Agency. The $300,000.00 contract is a Blanket Purchase Agreement (BPA) call to provide a variety of pharmaceutical products, including blood products, oncological pharmaceuticals, injectables, orals, and medical inhalations to address shortages. The contract has a period of performance through March 31, 2018 and uses a firm fixed-price pricing type. This BPA is part of a larger $2 million BPA vehicle awarded to TDS Med, Inc. in September 2019, which runs through September 2024. TDS Med, Inc. has previously supported COVID-19 response efforts and provided pharmaceutical products to address shortages to various federal agencies.
Description
Shortage pharmaceutical of items; including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and other relevant pharmaceuticals products including injectables, orals and medicinal inhalations
Quick answers
Who was awarded contract HT001417F0150?
HT001417F0150 was awarded to TDS Med, Inc. by Defense Health Agency (Department of Defense) on June 30, 2017.
How much is contract HT001417F0150 worth?
The government has obligated $300,000 on HT001417F0150.
Is contract HT001417F0150 an order under another contract?
Yes. HT001417F0150 is a BPA call under HT001414A0004, a blanket purchase agreement.
Was contract HT001417F0150 competed?
The extent of competition for HT001417F0150 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award